• No results found

H.V. Holm og medarbeidere svarer:

N/A
N/A
Protected

Academic year: 2022

Share "H.V. Holm og medarbeidere svarer:"

Copied!
2
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Standard care (androgen deprivation therapy) for patients with metastatic prostate cancer is almost universally accepted and the trials in the review compared different types

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of

Results: Compared to untreated (Ctrl) tumors, an improved and highly functional vascularization was detected in androgen-deprived (AD) tumors, reflected by increases in DCE

The survival benefit of dose-escalation with High-Dose-Rate brachytherapy (HDR-BT) combined with External Beam Radiotherapy (EBRT) for the treatment of high-risk prostate cancer

Abbreviations:AR, androgen receptor; BR, biochemical recurrence; CAPRA ‐ S, cancer of the prostate risk assessment postsurgical; DAB – 3 ′ , diaminobenzidine; FFPE, formalin

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall

Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).. Tidsskr

Dersom Tidsskriftet e er vårt opprinnelige ønske hadde akseptert et tidligere manus enten som oversiktsartikkel eller originalartikkel med, blant annet skildring av våre erfaringer